Suppr超能文献

尿液生物标志物和电解质在心力衰竭管理中的应用

Utility of Urine Biomarkers and Electrolytes for the Management of Heart Failure.

作者信息

Verbrugge Frederik Hendrik

机构信息

Department of General Internal Medicine, UZ Leuven, Herestraat 49, 3000, Leuven, Belgium.

出版信息

Curr Heart Fail Rep. 2019 Dec;16(6):240-249. doi: 10.1007/s11897-019-00444-z.

Abstract

PURPOSE OF REVIEW

To provide insight into the role of urine biomarkers and electrolytes for the management of heart failure.

RECENT FINDINGS

The age-dependent decrease in glomerular filtration rate due to loss of functional nephrons occurs at a faster pace in heart failure, potentially exacerbated by episodes of acute kidney injury. Urine biomarkers have not convincingly demonstrated to improve detection of irreversible renal damage and predict long-term renal trajectories, compared with serial creatinine measurements. Recent data show that natriuresis and diuretic response track poorly with glomerular filtration, but strongly with prognosis. Urine sodium concentration > 50-70 mmol/L was recently put forward through expert consensus as an adequate diuretic response. The value of urine biomarkers to detect structural renal damage in heart failure remains unsure and the latter is probably uncommon, especially over short-term follow-up. Urine electrolytes on the other hand predict diuretic response accurately and may allow better diuretic titration.

摘要

综述目的

深入探讨尿液生物标志物和电解质在心力衰竭管理中的作用。

最新发现

由于功能性肾单位丧失导致的肾小球滤过率随年龄下降在心力衰竭中发生得更快,急性肾损伤发作可能会加剧这种情况。与连续测量肌酐相比,尿液生物标志物尚未令人信服地证明能改善对不可逆肾损伤的检测并预测长期肾脏轨迹。最近的数据表明,利钠作用和利尿反应与肾小球滤过的相关性较差,但与预后密切相关。最近通过专家共识提出,尿钠浓度>50 - 70 mmol/L 为充分的利尿反应。尿液生物标志物在检测心力衰竭中结构性肾损伤方面的价值仍不确定,而且后者可能并不常见,尤其是在短期随访中。另一方面,尿液电解质能准确预测利尿反应,可能有助于更好地进行利尿剂滴定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验